With the updated National Instituite of Clinical Excellence (NICE) guidance expanding funding eligibility to offer flash glucose monitoring to all patients with type 1 diabetes and allow consideration for certain patients taking insulin for type 2 diabetes,13 we expect the uptake of isCGM to increase, particularly in older adults with type 2 diabetes. Here, INS is linked to type 2 diabetes mellitus.